企業プロフィール
BioStem Technologies 株価・ニュース・カタリスト
- ティッカー:
- BSEM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
3.00 USD (-6.54%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
Following the latest company update, “BioStem Technologies to Present at the Sidoti MicroCap Conference”, BSEM closed down 6.54% at $3.00 on Aug 17, 2026. The move occurred in the trading session associated with this conference / presentation update.
企業概要
Perinatal Tissue Regenerative Medicine Company
BioStem Technologies develops, manufactures, and commercializes allograft products derived from perinatal tissue. Its products are used across multiple specialties, particularly surgical care and wound management.
Processing Technology and Product Portfolio
The company uses proprietary BioRetain, CryoTek, and SteriTek processing methods intended to preserve the natural properties of donated tissue. Its brands include Neox, Clarix, VENDAJE, and American Amnion.
Hospital Commercialization Transition
Following the acquisition of BioTissue surgical and wound-care assets, BioStem is building a broader hospital-focused commercial organization, expanding its direct sales team and group purchasing organization coverage. The release did not identify a specific asset-level clinical or regulatory catalyst.
今後のカタリスト
- BioStem Technologies’ catalysts are wound-care product adoption and any commercial update that shows the regenerative-medicine platform is scaling. The market will care about recurring demand.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。